2026年11月3日星期二
M
Catatan Universal
Berita Kilat Global
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial

Sumber Nature 医学研究1 hari lalu
Ringkasan konten

Situs ini hanya menyediakan indeks judul dan ringkasan, konten lengkap dan hak cipta sepenuhnya milik penerbit asli, silakan klik tautan asli untuk membaca.

Buka artikel asli
Saluran terkait
Kesehatan
Wilayah terkait
Perspektif global
Bahasa asli
English
Nomor entri
health-5750ab15

Comments 0 comments

No comments yet. Be the first.

Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial · Catatan Universal